ArticleThe Journal of allergy and clinical immunology2023

Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutations.

Binni Kunvarjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.